Tata Consultancy Services’ (TCS) cloud-based clinical solutions and services suite -- TCS Advanced Drug Development (ADD), has won an award in the category Excellence in Ancillary Pharma Services, at the India Pharma Awards 2019.
The India Pharma Awards bring together industry pioneers and recognize outstanding examples of innovation that improve the pharma industry. The company was recognized for its leadership in leveraging automation, artificial intelligence (AI) and IoT through its intellectual property and commercial-off-the-shelf offerings, to digitize and transform patient engagement, metadata management and regulatory submissions for life sciences organizations.
Tata Consultancy Services is an IT services, consulting and business solutions provider that has been partnering with the world’s largest businesses in their transformation journeys for the last fifty years.
| Company Name | CMP |
|---|---|
| TCS | 2581.65 |
| Infosys | 1318.60 |
| HCL Tech. | 1442.50 |
| Wipro | 204.35 |
| Tech Mahindra | 1511.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: